Ami Neuberger
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 10
-
- Antibiotic Use and Resistance 7
- Endocrinology top 2%
- Vibrio bacteria research studies 5
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 5
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 6
-
- Pneumonia and Respiratory Infections 9
-
- Mosquito-borne diseases and control 6
- Co-authors
- Mical PaulD. RittelKhetam HusseinDafna YahavRoni BittermanJoseph OkebeAyelet Raz‐PasteurEli Schwartz
- Journals
- Journal of Travel Medicine (8 papers)Clinical Microbiology and Infection (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (5 papers)
- Partner nations
- IsraelNepalUnited Kingdom
In The Last Decade
Ami Neuberger
69 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 146
- Molecular Medicine 364
- Applied Microbiology and Biotechnology 141
- Endocrinology 195
- Infectious Diseases 410
- Clinical Biochemistry 139
Countries citing papers authored by Ami Neuberger
This map shows the geographic impact of Ami Neuberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Neuberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Neuberger more than expected).
Fields of papers citing papers by Ami Neuberger
This network shows the impact of papers produced by Ami Neuberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Neuberger. The network helps show where Ami Neuberger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ami Neuberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2021 | 16 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 11 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 4 | |
| 9 | 2018 | 23 | |
| 10 | 2017 | 27 | |
| 11 | 2017 | 81 | |
| 12 | 2016 | 23 | |
| 13 | 2015 | 101 | |
| 14 | 2014 | 9 | |
| 15 | Antimicrobial drugs for treating cholera (Review) | 2014 | 2 |
| 16 | 2014 | 6 | |
| 17 | 2014 | 4 | |
| 18 | 2013 | 10 | |
| 19 | 2012 | 9 | |
| 20 | 2011 | 4 |
About Ami Neuberger
Ami Neuberger is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrinology, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Pneumonia and Respiratory Infections (9 papers), COVID-19 Clinical Research Studies (7 papers), Antibiotic Use and Resistance (7 papers), Mosquito-borne diseases and control (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Vibrio bacteria research studies (5 papers). The work is most often cited by research in Molecular Medicine (364 citations), Applied Microbiology and Biotechnology (141 citations) and Endocrinology (195 citations). Ami Neuberger has collaborated with scholars based in Israel, Nepal and United Kingdom. Frequent co-authors include Mical Paul, D. Rittel, Khetam Hussein, Dafna Yahav, Roni Bitterman, Joseph Okebe, Ayelet Raz‐Pasteur, Eli Schwartz, I. Oren and Yuval Geffen. Their work appears in journals such as Journal of Travel Medicine, Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases, American Journal of Tropical Medicine and Hygiene and Cochrane Database of Systematic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.